It’s been almost exactly one year since I updated my list of healthcare venture capital funds with money to invest. I posted updates nine times between late 2010 and late 2012, so a new version is way overdue.
Today, I’m happy to provide an updated list, complete through 2013. While 2013 was no 2003, there are still lots of new funding sources looking to invest in great healthcare startups. Further, Bruce Booth of Atlas Venture predicts that “several other high profile life science funds are ramping up for 2014 fundraises.”
I’ve again included some non-VC firms in the list, as financing can sometimes come as debt, private equity and/or sales-of-future-royalties. I’ve also included some announcements from firms that are no longer investing, as it’s best to identify those firms early.
Lots of great individual contributors ask to become managers. They reach a point in their career where a management role seems like the next logical step up. The management path appears to offer more authority, and probably more money.
Unfortunately, success as an individual contributor is no guarantee of success as a manager, and many high-performing individuals find out later that they hate the responsibilities of management. They hate the amount of time they spend in meetings. They dread the planning and budgeting. They can’t stand dealing with personnel issues. They find themselves putting off work on performance reviews. They don’t effectively delegate tasks, because they can more easily perform the tasks themselves.
So, how do you know if you’re cut out to be a manager? Here are a few telltale signs: Continue reading
Fall in New England. (Photo credit: Wikipedia)
According to PWC’s recent quarterly MoneyTree report, no new medical device companies achieved Series A fundings in New England in either Q2 or Q3 2013. Zilch, zip, zero, nothin’, no, nada.
I’ve been tracking first-time venture financing of medical device companies in Nw England since 2005. You’ll find the link to my latest list of these companies at the bottom of this post. I wish I had a better update to offer.
What’s causing this New England drought?
Every once in a great while I read something so well stated that I put down my book/ipad/kindle and just reflect.
So when I recently read a post from Mike Sellers on Quora, I had to share it with you. Mike was responding to the question “As first time entrepreneurs, what part of the process are people often completely blind to?“
Mike wrote beautifully about software companies (read his original post here).
I’d tweak his words slightly for medical devices. Here’s my modified version of Mike’s post: Continue reading
My blog has gone pretty quiet for the last couple of months – an effect of the pace of a high-performance startup. After all, extraordinary achievement requires extraordinary effort.
We start new medical device companies to achieve extraordinary outcomes:
For patients, dramatic improvements in mortality, morbidity and quality-of-life.
For physicians, new and better options for patient care.
For providers and payers, meaningful reductions in the cost of care.
For our investors, healthy returns on investment.
For our families, providing for our future.
For ourselves, the exhilarating experience of extraordinary achievement.
And it truly is exhilarating. Continue reading
Like virtually all cataract surgery patients, my parents were thrilled with their cataract procedures. Why not? After a quick office procedure, their new intraocular lenses (IOLs) gave them better vision than they had experienced for more than a decade.
Now imagine a world with no devices for cataracts, only drugs. Imagine taking one or more medications every day for the rest of your life – drugs which could not cure cataracts, but which slow the inevitable progression towards blindness. Imagine the typical chronic-medication side effects: somewhere between minor discomfort and an increased risk of cardiovascular mortality. How does that sound?
When given a choice, I’ll take medical devices over drugs every time. Here’s why.
The latest quarterly MoneyTree Report was just released, providing some insight into the state of medical device venture funding in the US. I downloaded and plotted the historical trend data for medical device VC investments in the U.S. from Q1 1995 to Q1 2013. Click on the thumbnails for larger images.
What do the trends tell us?
Posted in Medical Device Startup Equity, Medical Device Venture Capital
Tagged Business, Fundraising, Health care, Investment, Life science, Medical and Life Sciences, Medical device, startup, Startup company, Venture capital
My colleague Chris recently noted: “the right way to do things is often a pain in the butt.” No question that most engineers see protocols as a pain in the butt – yet another file to sherpa through the document approval process.
There’s an important logic behind the practice of doing protocols. Imagine doing an experiment on humans (aka a clinical study) without one. But “good product development practice” isn’t the only reason star medical device engineers write protocols. Believe it or not, star medical device engineers view protocol writing as a key element of team leadership and team effectiveness.
Let me explain. Continue reading
In 2011 I urged extreme caution for medical device companies considering selling products through physician-owned distributorships (Caution: Physician-Owned Distributorships Ahead). This week, the US Office of the Inspector General (US OIG) issued a fraud alert for physician-owned distributorships, stating that “OIG views PODs as inherently suspect.” Don’t say I didn’t warn you.
Sir Ronald Aylmer Fisher FRS
If you haven’t learned to fear adhesive bonds, you haven’t lived a complete medical device life. Adhesives are truly marvels of transmutation: liquids stay liquid until they magically become solid, and a drop or two of base substance can hold dissimilar materials together with superhuman strength.
Yet control of adhesive processes is always a nightmare. UV fluence or position changes from lamp-to-lamp, and oven temperature varies seasonally. The environment is always too damp or too dry. Dispenser accuracy varies. Somehow the location of your adhesive on today’s device has shifted slightly from last year’s location. With adhesives, you just never know which variable is going to cross the line from in-control to out-of-control. You don’t need a masters in statistics to see that a large number of low-probability process failures adds up to a higher-than-desirable probability of bond failure.
I routinely bore people with my assertion that everyone should be required to study and master statistics in high school. We all need statistics to better understand the world we live in and the news we read. Without statistics literacy, we can easily be misled. In our personal lives, we make financial investments, buy insurance, and make decisions with risks. At work, engineers and scientists need statistics to understand designs, processes and experiments. Sales and marketing people need statistics to understand market attractiveness and sales probabilities. Supply chain and operations experts need statistics to understand forecasts, materials plans, and manufacturing processes. Even accountants and finance types need statistics to understand currency risks, stock options, and financial instruments.
Star medical device engineers master statistics to make better designs in less time. How? Continue reading